Share
Markers in Cancer: A joint meeting by ASCO, EORTC and NCI
November 7, 2013 - November 9, 2013
Venue: Brussels, Belgium
Next generation sequencing and high throughput screening technologies are revolutionizing our current molecular understanding of cancer. Molecular tumor profiles can now be established at affordable cost within a timeframe compatible with clinical practice. It is anticipated, that biomarker-based patient selection will soon move to the forefront of effective cancer treatment.
Markers in Cancer, a joint meeting by ASCO, EORTC & NCI, will focus on the relevance and the feasibility of implementing emerging technologies into clinical practice.
A tutorial on biomarker development dealing with issues related to next generation trial design (5-7 November 2013) will precede the Main Meeting and is open to early career oncologists.
Next events
EORTC Lymphoma Group Spring Meeting
March 10
Amsterdam, Netherlands
EORTC Brain Tumour Group Spring Meeting
March 17
Brussels, Belgium (hybrid)
ESMO Sarcoma and Rare Cancers Annual Congress
March 20 - March 22
Lugano, Italy
EORTC Imaging Group Spring Meeting
March 20
Brussels, Belgium (hybrid)
EORTC Melanoma Group Spring Meeting
March 23 - March 24
Berlin, Germany